After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
IONS belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Ionis Pharmaceuticals Inc is $5.72B. A total of 1.65 million shares were traded on the day, compared to an average of 1.47M shares.
In the most recent transaction, Swayze Eric sold 1,194 shares of IONS for 37.92 per share on Nov 12 ’24. After the transaction, the EVP Research now owns 33,713 company shares. In a previous transaction on Nov 12 ’24, Monia Brett P sold 6,630 shares at 38.05 per share. IONS shares that Chief Executive Officer owns now total 167,393.
Among the insiders who sold shares, LOSCALZO JOSEPH disposed of 13,508 shares on Nov 12 ’24 at a per-share price of $37.86. This resulted in the Director holding 32,251 shares of IONS after the transaction. In another insider transaction, Monia Brett P bought 6,629 shares at $38.89 per share on Nov 12 ’24.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, IONS has a high of $54.44 and a low of $33.33.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. IONS’s latest balance sheet shows that the firm has $2.11B in Cash & Short Term Investments as of fiscal 2021. There were $1.25B in debt and $240.55M in liabilities at the time. Its Book Value Per Share was $4.20, while its Total Shareholder’s Equity was $771.74M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IONS is Buy with a score of 4.14.
